Coherus Oncology, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CHRS Nasdaq 2830 www.coherus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Coherus Oncology, Inc.

Will Coherus Oncology (CHRS) Report Negative Earnings Next Week? What You Should Know - Nov 2nd, 2026 7:00 am
Coherus Oncology Reports 89% Response Rate in Early ESCC Study - Oct 28th, 2026 6:04 pm
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development - Oct 28th, 2026 2:05 pm
Coherus to Participate in Upcoming Investor Conferences - Oct 27th, 2026 7:30 am
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026 - Oct 26th, 2026 7:30 am
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026 - Oct 14th, 2026 2:30 pm
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets - Sep 23rd, 2026 7:30 am
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights - Aug 17th, 2026 3:33 pm
Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 6:31 pm
Coherus Oncology, Inc. Q2 2026 Earnings Call Summary - Aug 6th, 2026 6:30 am
Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: LOQTORZI Growth and Pipeline ... - Aug 5th, 2026 11:03 pm
Coherus Oncology Q2 Earnings Call Highlights - Aug 5th, 2026 6:04 pm
Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates - Aug 5th, 2026 4:10 pm
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:28 pm
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 - Jul 22nd, 2026 11:36 am
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi) - Jun 23rd, 2026 12:00 pm
Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors - Jun 11th, 2026 5:39 am
What You Need To Know About The Coherus Oncology, Inc. (NASDAQ:CHRS) Analyst Downgrade Today - May 14th, 2026 6:16 am